For years, Vitafoam Nigeria Plc delivered predictable results, but investors rarely celebrated it.
However, in 2024, revenue climbed 56%, yet foreign exchange losses of ₦12.7 billion crushed earnings.
Consequently, the share price barely moved, reflecting profit struggles despite strong revenue growth.
Vitafoam Steady Beginnings
Then 2025 arrived, and the company transformed dramatically.
Firstly, revenue jumped to ₦111 billion, over 40% of total revenue from the last five years.
Meanwhile, foreign exchange losses fell sharply to ₦619 million, allowing profits to flow to shareholders.
As a result, profit attributable to shareholders surged to ₦13.5 billion, with earnings per share reaching ₦10.80.
Additionally, gross profit margin held at 37%, proving the company maintained genuine profitability.
Moreover, net cash flow from operations rose to ₦15.2 billion, up from ₦3.3 billion the prior year.
At the same time, retained earnings increased to ₦25.9 billion, strengthening the company’s balance sheet.
Market Surge
Investors quickly noticed: the stock surged 300% in 2025, outperforming peers and the NGX All-Share Index.
Read Also: Lagos Plans Electric Boats To Cut Ferry Fares In 2026
In early 2026, the stock climbed to ₦97.80, raising market capitalisation to ₦122.3 billion.
This figure now exceeds three times the company’s net assets reported in September 2025.
Furthermore, Vitafoam declared a ₦3 cash dividend per share and announced a bonus share issue.
The qualification date is February 6, 2026, with cash payment scheduled for March 5, 2026.
Consequently, investors now ask: should they lock in gains or continue holding for future growth?
Analysts note that 2025’s surge stemmed mainly from lower foreign exchange losses after a weak 2024.
Looking ahead, future returns will depend on steady volume growth, cost discipline, and sustained cash generation.
Long-Term Outlook
Short-term traders might take profits, but long-term investors can benefit from compounding wealth.
Overall, Vitafoam now operates stronger, more profitable, and more cash-generative than it did two years ago.
Thus, the 2025 turnaround marked a turning point, transforming a cautious stock into an investor favourite.
With a healthier balance sheet, rising dividends, and consistent cash flow, the company continues its growth journey.
Finally, investors must weigh past gains against potential growth and make careful decisions about the stock.
